Starboard's Smith targeting pharma firm for proxy fight
May 04, 2016 at 14:40 PM EDT
Starboard Value is making a move against a pharmaceutical company it says is mismanaged, CEO Jeff Smith said Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.